June 28, 2017

Nutrition21 Presents Three Preclinical Scientific Studies on Velositol at ISSN

James Komorowski, MS, CNS, vice president of scientific and regulatory affairs at Nutrition 21, presented the results of three preclinical studies on Nutrition 21’s patented amylopectin and chromium combination ingredient, Velositol, at the ISSN (International Society of Sports Nutrition) conference on June 24th in Phoenix.

DOWNLOAD THE PDF
DOWNLOAD THE PDF

more news

MORE NEWS
Ingredients

Chromax®Lustriva®Nitrosigine®NooLVL®Velositol®Zinmax®

More

AboutMeet the Sales TeamInnovationQualityProduct ProtectionWhere to FindPress RoomBlogContact

Get in Touch

[email protected]

250 Pehle AvenueSuite 200Saddle Brook, NJ 07663

Nutrition21 Proudly Supports the Following Industry Associations

N21 New Footer Image V2 uai Nutrition21

©2023 Nutrition21, LLC. All rights reserved.       

Nitrosigine®, Velositol®, nooLVL®, Lustriva®, Chromax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC.  All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,028,879; 9,119,835; 9,597,404; 9,675,702; 10,183,049; and 10,245,325.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.